| Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review PI Rafailidis, EG Mourtzoukou, IC Varbobitis, ME Falagas Virology journal 5, 1-7, 2008 | 747 | 2008 |
| Complement and tissue factor–enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis P Skendros, A Mitsios, A Chrysanthopoulou, DC Mastellos, S Metallidis, ... The Journal of clinical investigation 130 (11), 6151-6157, 2020 | 671 | 2020 |
| β-D-Glucan Assay for the Diagnosis of Invasive Fungal Infections: A Meta-analysis DE Karageorgopoulos, EK Vouloumanou, F Ntziora, A Michalopoulos, ... Clinical Infectious Diseases 52 (6), 750-770, 2011 | 655 | 2011 |
| Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence ME Falagas, P Lourida, P Poulikakos, PI Rafailidis, GS Tansarli Antimicrobial agents and chemotherapy 58 (2), 654-663, 2014 | 444 | 2014 |
| Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamases: a systematic review and meta … KZ Vardakas, GS Tansarli, PI Rafailidis, ME Falagas Journal of antimicrobial chemotherapy 67 (12), 2793-2803, 2012 | 439 | 2012 |
| Fosfomycin: use beyond urinary tract and gastrointestinal infections ME Falagas, KP Giannopoulou, GN Kokolakis, PI Rafailidis Clinical infectious diseases 46 (7), 1069-1077, 2008 | 410 | 2008 |
| Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients ME Falagas, PI Rafailidis, E Ioannidou, VG Alexiou, DK Matthaiou, ... International journal of antimicrobial agents 35 (2), 194-199, 2010 | 360 | 2010 |
| Resistance to polymyxins: mechanisms, frequency and treatment options ME Falagas, PI Rafailidis, DK Matthaiou Drug resistance updates 13 (4-5), 132-138, 2010 | 355 | 2010 |
| Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case–control study ME Falagas, PI Rafailidis, D Kofteridis, S Virtzili, FC Chelvatzoglou, ... Journal of antimicrobial chemotherapy 60 (5), 1124-1130, 2007 | 322 | 2007 |
| Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence T Kelesidis, I Kelesidis, PI Rafailidis, ME Falagas Journal of Antimicrobial Chemotherapy 60 (2), 214-236, 2007 | 320 | 2007 |
| Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence KZ Vardakas, KA Polyzos, K Patouni, PI Rafailidis, G Samonis, ... International journal of antimicrobial agents 40 (1), 1-8, 2012 | 304 | 2012 |
| The effect of psychosocial factors on breast cancer outcome: a systematic review ME Falagas, EA Zarkadoulia, EN Ioannidou, G Peppas, C Christodoulou, ... Breast Cancer Research 9, 1-23, 2007 | 291 | 2007 |
| Worldwide prevalence of head lice ME Falagas, DK Matthaiou, PI Rafailidis, G Panos, G Pappas Emerging infectious diseases 14 (9), 1493-1494, 2008 | 287 | 2008 |
| Attributable mortality of Acinetobacter baumannii: no longer a controversial issue ME Falagas, PI Rafailidis Critical care 11, 1-3, 2007 | 277 | 2007 |
| Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials ME Falagas, EK Vouloumanou, AG Togias, M Karadima, AM Kapaskelis, ... Journal of Antimicrobial Chemotherapy 65 (9), 1862-1877, 2010 | 264 | 2010 |
| Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies ME Falagas, AC Kastoris, DE Karageorgopoulos, PI Rafailidis International journal of antimicrobial agents 34 (2), 111-120, 2009 | 253 | 2009 |
| Antibiotics versus placebo in the treatment of women with uncomplicated cystitis: a meta-analysis of randomized controlled trials ME Falagas, IK Kotsantis, EK Vouloumanou, PI Rafailidis Journal of Infection 58 (2), 91-102, 2009 | 246 | 2009 |
| Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation A Michalopoulos, S Virtzili, P Rafailidis, G Chalevelakis, M Damala, ... Clinical microbiology and infection 16 (2), 184-186, 2010 | 242 | 2010 |
| Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective … N Markou, SL Markantonis, E Dimitrakis, D Panidis, E Boutzouka, ... Clinical therapeutics 30 (1), 143-151, 2008 | 227 | 2008 |
| Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study DK Matthaiou, A Michalopoulos, PI Rafailidis, DE Karageorgopoulos, ... Critical care medicine 36 (3), 807-811, 2008 | 213 | 2008 |
